• MLKL Polymerization Drives Lysosomal Permeabilization in Nec

  2026-06-10

  This article examines new evidence revealing how MLKL polymerization directly induces lysosomal membrane permeabilization (LMP), facilitating cathepsin B release and promoting necroptosis. The findings provide mechanistic clarity on the sequence and molecular executors of regulated necrotic cell death, opening avenues for targeted intervention in inflammation and cell death research.

• Amplex Red: Sensitive ROS Detection and Assay Optimization

  2026-06-10

  Amplex Red (10-Acetyl-3,7-dihydroxyphenoxazine) enables ultrasensitive detection of hydrogen peroxide and peroxidase activity, powering advanced oxidative stress monitoring workflows. Discover how recent mechanistic insights refine experimental design and troubleshooting to maximize accuracy across cell-based and high-throughput assays.

• ATM Inhibition and Nuclear cGAS: New Frontiers in DDR Resear

  2026-06-09

  This thought-leadership article provides a synthesis of recent advances in DNA damage response (DDR) modulation, focusing on the mechanistic interplay between ATM kinase inhibition and nuclear cGAS activity. We explore how KU-55933, a potent ATM kinase inhibitor from APExBIO, empowers translational researchers to dissect and manipulate genome stability pathways, with strategic insights into protocol design, experimental rigor, and the future of precision oncology. Drawing on recent landmark studies, the article offers a differentiated perspective that bridges molecular mechanisms, practical workflows, and visionary translational opportunities.

• NIR-Triggered Co-SAE Enables Multimodal ROS-Driven Photother

  2026-06-09

  This study introduces a near-infrared (NIR) activated cobalt single-atom enzyme (Co-SAE) anchored on N-doped carbon spheres, designed to amplify highly reactive oxygen species (hROS) and induce mild hyperthermia for synergistic photodynamic, photocatalytic, and photothermal therapy. The approach demonstrates efficient tumor ablation in head and neck cancer models, while minimizing collateral tissue damage, marking a significant advancement in noninvasive cancer therapy.

• VX-765: Potent Caspase-1 Inhibitor for Pyroptosis Research

  2026-06-08

  VX-765 is a potent, selective, orally absorbed caspase-1 inhibitor that blocks the maturation of key pro-inflammatory cytokines IL-1β and IL-18. Its active metabolite, VRT-043198, enables precise dissection of inflammasome signaling and pyroptosis in macrophages. VX-765 is validated in preclinical models relevant to inflammation and infectious diseases.

• Verbascoside as a PKC/NF-κB Inhibitor: Workflows and Innovat

  2026-06-08

  Verbascoside from APExBIO stands out as a robust PKC/NF-κB inhibitor for dissecting osteoclastogenesis and neuroinflammatory signaling. This guide details evidence-based workflows, troubleshooting strategies, and key innovations that help researchers maximize reproducibility in cell signaling and bone metabolism studies.

• Phosphotungstic Acid Negative Stain Solution (2%): EM Benchm

  2026-06-07

  Phosphotungstic Acid Negative Stain Solution (2%) delivers high-contrast electron microscopy for biological specimens. Its optimized 2% formulation from APExBIO enhances visualization of viruses and macromolecules, supporting reliable imaging and translational virology. Protocol adherence and understanding of stain limitations are essential for reproducible results.

• Spatial Sampling of Infection Dynamics in Ambrosia Beetle Co

  2026-06-06

  Masoudi et al. present a detailed protocol for investigating the spatial dynamics of infectious disease and pathogen spread within social ambrosia beetle colonies. By integrating rearing, infection assays, spatial sampling, and imaging, the study advances methodologies for exploring microbe-insect interactions and transmission processes in complex colony systems.

• Annexin V-PE Reagent: Precision Apoptosis Detection Workflow

  2026-06-05

  Annexin V-PE Reagent streamlines early apoptosis detection with rapid, one-step staining and robust sensitivity, making it indispensable for CAR-T research and cell death assays. This guide details protocol enhancements, troubleshooting strategies, and how structural immunology advances inform assay optimization.

• IRG1-Itaconic Acid Axis Regulates TBK1 and Type I IFN Respon

  2026-06-05

  Chai et al. elucidate a metabolic feedback mechanism where IRG1-driven itaconic acid production alkylates TBK1, restraining type I interferon signaling during viral infection. This insight clarifies links between immunometabolism and antiviral response control, with implications for hyperinflammation therapies.

• Deferasirox Pharmacokinetics and Clinical Experience in Iron

  2026-06-04

  This article reviews the pivotal findings of Galanello et al. (2012) on the pharmacokinetics, efficacy, and safety of Deferasirox (Exjade) as an oral iron chelator for managing chronic iron overload in transfusion-dependent anemias. The study's insights inform experimental design and therapeutic approaches for iron chelation, particularly in beta-thalassemia and related disorders.

• Quercetin as a PI3K Inhibitor: Applied Workflows in Cancer R

  2026-06-04

  Quercetin stands out as a potent PI3K inhibitor and apoptosis inducer, offering translational advantages for cancer and liver pathology research. This article details advanced experimental workflows, troubleshooting strategies, and key innovations that make APExBIO’s Quercetin (SKU N1841) an indispensable reagent for mechanistic studies and therapeutic modeling.

• Irinotecan (CPT-11): Advanced Workflow Optimization in Color

  2026-06-03

  Unlock the full translational impact of Irinotecan (CPT-11) with workflow enhancements that drive reproducible DNA damage and apoptosis assays in colorectal cancer models. This guide delivers protocol precision, troubleshooting strategies, and actionable insights for maximizing tumor growth suppression and preclinical assay rigor.

• AICAR phosphate (Acadesine): Reliable AMPK Activation in B-C

  2026-06-03

  This article addresses common laboratory challenges in cell viability, apoptosis, and immunometabolic research by providing scenario-driven guidance on deploying AICAR phosphate (Acadesine), SKU B1211. Drawing on high-purity product data and recent literature, it demonstrates how this compound ensures reproducibility and mechanistic clarity in cancer and CNS studies. Researchers will find workflow-anchored answers, protocol tips, and evidence-backed recommendations for experimental success.

• Targeting PI3K Pathway Complexity: GDC-0941 for Translationa

  2026-06-02

  This thought-leadership article explores the mechanistic foundations and translational strategies for leveraging GDC-0941, a potent PI3K inhibitor, in overcoming tumorigenic signaling complexity and resistance in oncology. We synthesize recent advances with actionable protocol guidance and position APExBIO's GDC-0941 as an advanced tool for researchers seeking robust, reproducible results in PI3K/Akt pathway studies and beyond.

16150 records 1/1077 page Next 12345 下5页 Last page